Endoscopic balloon dilatation of the prostate

28 patients who had symptoms of prostatism were treated by endoscopic balloon dilatation of the prostate [EBDP]. Their age ranges between 52 and 80 years [mean 66.5]. One month after dilatation 75% of patients demonstrated at least 25% improvement in subjective [symptom score] and 64.2% showed the same improvement in objective [Q max]. After 4 months the improvement in symptom score decreased to 71.4% and to 57.1% in Q max. Complications included mild bleeding, postoperative pain and urinary tract infection

Role of intravesical BCG for the treatment of superficial bladder cancer

A controlled trial was performed on 30 patients to evaluate the efficacy of intravesical Pasteur strain bacillus Calmetle-Guerin [BCG] administration as a prophylaxis against tumor recurrence after complete endoscopic resection of superficial bladder cancer. The treatment schedule consisting of 6 weeks course of BCG instillation 10 days after transurethral resection of bladder tumor [TURT]. Patients who were treated with BCG were significantly better as regards to tumor recurrence, the tumor free interval, stage and grade of the recurrent tumors is significantly better than the control group